PNPLA3 and metabolic dysfunction-associated steatohepatitis: The I148M variant of PNPLA3 is likely the major genetic determinant of increased hepatic fat content by interacting with body fat and dietary factors [8, 54, 60, 62], but it also influences the susceptibility to NASH and fibrosis, [278].